KR20140107651A - 클로드론산 및 히알루론산을 포함하는 골관절염 치료용 약학적 제제 - Google Patents

클로드론산 및 히알루론산을 포함하는 골관절염 치료용 약학적 제제 Download PDF

Info

Publication number
KR20140107651A
KR20140107651A KR1020147021224A KR20147021224A KR20140107651A KR 20140107651 A KR20140107651 A KR 20140107651A KR 1020147021224 A KR1020147021224 A KR 1020147021224A KR 20147021224 A KR20147021224 A KR 20147021224A KR 20140107651 A KR20140107651 A KR 20140107651A
Authority
KR
South Korea
Prior art keywords
acid
hyaluronic acid
treatment
sodium
osteoarthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020147021224A
Other languages
English (en)
Korean (ko)
Inventor
세르지오 로시니
실비아 트라스시아티
Original Assignee
아비오젠 파르마 에스피에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아비오젠 파르마 에스피에이 filed Critical 아비오젠 파르마 에스피에이
Publication of KR20140107651A publication Critical patent/KR20140107651A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
KR1020147021224A 2005-12-29 2006-12-21 클로드론산 및 히알루론산을 포함하는 골관절염 치료용 약학적 제제 Abandoned KR20140107651A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2005A002515 2005-12-29
IT002515A ITMI20052515A1 (it) 2005-12-29 2005-12-29 Formulazione farmaceutica per il trattamento della osteoartrite
PCT/EP2006/012367 WO2007073921A1 (en) 2005-12-29 2006-12-21 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020087015583A Division KR101470608B1 (ko) 2005-12-29 2008-06-26 클로드론산 및 히알루론산을 포함하는 골관절염 치료용약학적 제제

Publications (1)

Publication Number Publication Date
KR20140107651A true KR20140107651A (ko) 2014-09-04

Family

ID=36648609

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020147021224A Abandoned KR20140107651A (ko) 2005-12-29 2006-12-21 클로드론산 및 히알루론산을 포함하는 골관절염 치료용 약학적 제제
KR1020087015583A Active KR101470608B1 (ko) 2005-12-29 2008-06-26 클로드론산 및 히알루론산을 포함하는 골관절염 치료용약학적 제제

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020087015583A Active KR101470608B1 (ko) 2005-12-29 2008-06-26 클로드론산 및 히알루론산을 포함하는 골관절염 치료용약학적 제제

Country Status (20)

Country Link
US (4) US20090042833A1 (https=)
EP (1) EP1976538B1 (https=)
JP (1) JP2009522218A (https=)
KR (2) KR20140107651A (https=)
AT (1) ATE446763T1 (https=)
AU (1) AU2006331019B2 (https=)
CA (1) CA2646974C (https=)
CY (1) CY1109541T1 (https=)
DE (1) DE602006010111D1 (https=)
DK (1) DK1976538T3 (https=)
ES (1) ES2333615T3 (https=)
IT (1) ITMI20052515A1 (https=)
NO (1) NO340794B1 (https=)
NZ (1) NZ569420A (https=)
PL (1) PL1976538T3 (https=)
PT (1) PT1976538E (https=)
RU (1) RU2414908C2 (https=)
SI (1) SI1976538T1 (https=)
WO (1) WO2007073921A1 (https=)
ZA (1) ZA200805598B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120208757A1 (en) * 2010-10-07 2012-08-16 Excel Med, Llc Use of hyaluronan for promoting angiogenesis
JP6683700B2 (ja) 2014-11-07 2020-04-22 株式会社エキソステムテックＥｘｏｓｔｅｍｔｅｃｈ Ｃｏ．，Ｌｔｄ． 幹細胞由来のエキソソームを含有する脂肪細胞分化誘導、または脂肪組織の再生用組成物の製造方法
KR101706642B1 (ko) 2015-02-04 2017-02-17 주식회사 엑소스템텍 연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물
IT201600123773A1 (it) 2016-12-06 2018-06-06 Abiogen Pharma Spa Composizione per il trattamento dell’osteoartrosi
IT202100023894A1 (it) * 2021-09-16 2023-03-16 Professional Derma Sa Composizione per utilizzo in campo ortopedico
EP4450062A1 (en) 2023-04-20 2024-10-23 Abiogen Pharma S.p.A. Composition for the treatment of osteoarthrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
JP2001253827A (ja) * 2000-02-15 2001-09-18 Pfizer Prod Inc 骨粗鬆症を治療するための組成物および方法
JP3923800B2 (ja) * 2000-05-05 2007-06-06 エフ．ホフマン−ラ ロシュ アーゲー ビスホスホン酸またはそれらの塩を含む、皮下投与のためのゲル様医薬組成物
BR0310087A (pt) * 2002-05-17 2005-08-16 Wyeth Corp Veìculos sólidos injetáveis para ácido hialurÈnico para aplicação de proteìnas osteogênicas
KR100648515B1 (ko) * 2004-05-04 2006-11-27 (주)아모레퍼시픽 비스포스포네이트-함유 고분자 미립구를 포함하는 골-관련질환 치료 또는 예방용 서방 효과를 갖는 주사제

Also Published As

Publication number Publication date
US20200147126A1 (en) 2020-05-14
EP1976538B1 (en) 2009-10-28
WO2007073921A1 (en) 2007-07-05
RU2414908C2 (ru) 2011-03-27
DE602006010111D1 (de) 2009-12-10
RU2008126108A (ru) 2010-01-10
ATE446763T1 (de) 2009-11-15
US20180185407A1 (en) 2018-07-05
NO20082848L (no) 2008-08-27
ITMI20052515A1 (it) 2007-06-30
ES2333615T3 (es) 2010-02-24
AU2006331019A2 (en) 2009-01-22
PT1976538E (pt) 2009-12-07
KR101470608B1 (ko) 2014-12-09
DK1976538T3 (da) 2010-01-11
JP2009522218A (ja) 2009-06-11
ZA200805598B (en) 2009-11-25
SI1976538T1 (sl) 2010-01-29
NO340794B1 (no) 2017-06-19
US20140371170A1 (en) 2014-12-18
US20090042833A1 (en) 2009-02-12
US9943540B2 (en) 2018-04-17
HK1123986A1 (en) 2009-07-03
AU2006331019B2 (en) 2012-03-22
PL1976538T3 (pl) 2010-03-31
CA2646974C (en) 2013-06-11
AU2006331019A1 (en) 2007-07-05
KR20080082657A (ko) 2008-09-11
CY1109541T1 (el) 2014-08-13
NZ569420A (en) 2010-05-28
EP1976538A1 (en) 2008-10-08
CA2646974A1 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
Saravanakumar et al. Application of hyaluronic acid in tissue engineering, regenerative medicine, and nanomedicine: A review
KR101470608B1 (ko) 클로드론산 및 히알루론산을 포함하는 골관절염 치료용약학적 제제
CA2458853A1 (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
KR101900520B1 (ko) 복합 조성물
MX9805588A (es) Administracion oral de cantidades efectivas de formas de acido hialuronico.
MY144021A (en) Pharmaceutical delivery system
US20140038917A1 (en) Sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
KR20100112632A (ko) 수용성인 프로포폴 전구약물의 약제학적 수성 제제
KR101585868B1 (ko) 브래딘키닌 길항제 및 히알루론산을 함유하는 약제학적 조성물, 및 그의 용도
CA2385974A1 (en) Treating endometriosis or infertility or improving fertility
CA2516458A1 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
JP2009522218A5 (https=)
HK1123986B (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
IL319025A (en) Methods for treating or preventing endometriosis
MX2008008418A (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
CN101822689A (zh) 含有透明质酸和β-七叶皂苷钠的药物组合物
WO2021202990A2 (en) Methods for the treatment of betacoronavirus infections
CN111821423A (zh) 一种白介素2用于治疗慢性自发性荨麻疹的应用
EP2883541A1 (en) Composition for topical use comprising hyaluronic acid
CA2472957A1 (en) Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboembolic events in patients with deep venous thrombosis
KR101462212B1 (ko) 염증 억제용 약제학적 조성물 및 방법
Reginster Osteoporosis treatment: choices and options
HK1055258A (en) Oct preparations
HK1062524B (en) Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis
HK1062524A1 (en) Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee

St.27 status event code: A-2-2-U10-U14-oth-PC1904

St.27 status event code: N-2-6-B10-B12-nap-PC1904

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000